1. Home
  2. ELA vs TRDA Comparison

ELA vs TRDA Comparison

Compare ELA & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELA
  • TRDA
  • Stock Information
  • Founded
  • ELA 1965
  • TRDA 2016
  • Country
  • ELA United States
  • TRDA United States
  • Employees
  • ELA N/A
  • TRDA N/A
  • Industry
  • ELA Consumer Specialties
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELA Consumer Discretionary
  • TRDA Health Care
  • Exchange
  • ELA Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • ELA 195.3M
  • TRDA 233.5M
  • IPO Year
  • ELA N/A
  • TRDA 2021
  • Fundamental
  • Price
  • ELA $7.29
  • TRDA $5.85
  • Analyst Decision
  • ELA Strong Buy
  • TRDA Strong Buy
  • Analyst Count
  • ELA 1
  • TRDA 3
  • Target Price
  • ELA $9.00
  • TRDA $25.67
  • AVG Volume (30 Days)
  • ELA 63.5K
  • TRDA 363.1K
  • Earning Date
  • ELA 11-04-2025
  • TRDA 11-04-2025
  • Dividend Yield
  • ELA N/A
  • TRDA N/A
  • EPS Growth
  • ELA 34.09
  • TRDA N/A
  • EPS
  • ELA 0.33
  • TRDA N/A
  • Revenue
  • ELA $198,354,109.00
  • TRDA $79,476,000.00
  • Revenue This Year
  • ELA $14.43
  • TRDA N/A
  • Revenue Next Year
  • ELA $2.60
  • TRDA N/A
  • P/E Ratio
  • ELA $22.50
  • TRDA N/A
  • Revenue Growth
  • ELA 24.35
  • TRDA N/A
  • 52 Week Low
  • ELA $5.10
  • TRDA $4.93
  • 52 Week High
  • ELA $8.36
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • ELA 45.76
  • TRDA 55.82
  • Support Level
  • ELA $7.38
  • TRDA $5.65
  • Resistance Level
  • ELA $7.98
  • TRDA $6.16
  • Average True Range (ATR)
  • ELA 0.35
  • TRDA 0.30
  • MACD
  • ELA -0.11
  • TRDA 0.08
  • Stochastic Oscillator
  • ELA 12.70
  • TRDA 73.15

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: